RPRX
NASDAQ · Pharmaceuticals
Royalty Pharma Plc- Cl A
$58.52
+0.08 (+0.14%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
—
1Y
+61.48%
YTD
+50.59%
Open$58.27
Previous Close$58.44
Day High$59.03
Day Low$57.86
52W High$64.38
52W Low$34.63
Volume—
Avg Volume3.50M
Market Cap33.62B
P/E Ratio41.26
EPS$1.46
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$40.77
Above
SMA 200
$37.28
Above
RSI (14)
85.1
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
16 analysts
Price Target
-38.0% upside
Current
$58.52
$58.52
Target
$36.26
$36.26
$26.65
$36.26 avg
$40.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.43B | 2.38B | 6.69B |
| Net Income | 786.21M | 693.31M | 946.13M |
| Profit Margin | 32.4% | 30.8% | 14.1% |
| EBITDA | 1.59B | 1.48B | 1.13B |
| Free Cash Flow | — | — | 700.09M |
| Rev Growth | +2.1% | +2.1% | +2.6% |
| Debt/Equity | 1.38 | 1.38 | 0.41 |
Dividend
Dividend Yield2.96%
Annual Dividend$0.65
Payout Ratio49.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |